CareHub | Rewards Program

Rewards Program

Featured Topics

Browse Topics

Podcast Summary

Utilities

Ask Rupert

Crowdsource

Home

LaunchCareApp

The Care Gap Crisis

The universal care gap crisis extends across all chronic diseases. Patients with Cancer, Alzheimer's, Autism, Parkinson's, Long COVID, Obesity, Type II Diabetes, and Aged Care all face elevated depression, anxiety, burnout, and isolation.

The Award Program recognizes and celebrates the extraordinary courage of warriors, the unwavering dedication of their caregivers, and the healthcare providers delivering exceptional care. It combines meaningful rewards with permanent blockchain commemoration so support, visibility, and legacy are built into the model from the start.

Our Solution: Starting with Cancer warriors and caregivers to prove the model, recognition through rewards provides validation, reduces isolation, connects warriors to community support, and creates permanent blockchain-preserved testimonials that inspire thousands globally.

This model combines immediate financial relief, reduced isolation, global inspiration, and long-term societal value while scaling across all 8 chronic disease communities.

Financial rewards Scale with Success: The 2026 enterprise forecast spans $10.8M-$22.8M ARR, which implies a launch-year rewards budget range of roughly $6.3K-$13.3K while maintaining the same award-intensity ratio.

Transformational Impact

Immediate Relief: Financial rewards provide critical support for treatment costs, living expenses, and emergency needs
Mental Health Support: Recognition reduces depression, anxiety, and isolation through community connection
Family Support: Caregivers receive validation and relief from the invisible burden they carry
Global Inspiration: Blockchain-preserved stories inspire countless others facing similar battles worldwide
Lasting Legacy: Permanent commemoration ensures courage is never forgotten

Built for Sustainability

Long-Term Sustainability Features

4% Total Token Allocation: Streamlined model focused on high-impact annual rewards plus quarterly creative recognition
Indefinite Program Duration: Pre-IPO uses token reserve; post-IPO switches to cash rewards funded by revenue buyback mechanisms
No Additional Dilution: Post-IPO rewards are funded from operating cash flow, not new token issuance
Governance-Driven Expansion: Token holders vote on timing and allocation for each new disease community
Inflation Buffer: Allocation includes cushion given token appreciation outpaces CPI in growth scenarios

Sustainable Funding Model

The program is designed to operate indefinitely through enterprise revenue and treasury discipline.

Funding Sources

Buyback Program: Enterprise revenues continuously replenish the award pool
Token Appreciation: Fewer tokens are needed over time to maintain target award values
Reserve Discipline: Treasury structure preserves long-run purchasing power

Governance and Transparency

Community-Driven Decisions: Token holders vote on award amounts, new disease community additions, and expansion timing so the model scales in step with proof of impact.

Permanent Preservation of Stories

Capturing these stories in video format and preserving them on the blockchain creates a permanent, globally accessible testament to their experiences that transcends traditional boundaries.

Why Blockchain?

Permanent Record: Stories preserved forever, immune to censorship or deletion
Global Accessibility: Anyone, anywhere can access these narratives
Personalized Stories: Video creation ensures each story is unique
Democratized Access: No geographic or socioeconomic barriers
Inspiration at Scale: Wisdom shared with countless others facing similar battles

Key Balancing Factors

This structure balances several critical factors to ensure program success and sustainability.

1. Recipient Flexibility

Recipients can liquidate when needed or choose to reinvest in the fund while benefiting from token appreciation.

2. Market Stability

Staggered releases and quarterly distributions reduce shock from simultaneous selling.

3. Program Perpetuity

The program can continue indefinitely through buybacks, enterprise revenue, and governance-approved adjustments.

4. Reasonable Dilution

Total dilution remains controlled over time, maintaining token holder confidence.

5. Meaningful Impact

Award values from $100 to $5,000 provide meaningful support while maintaining token value stability.

Program Architecture at a Glance

rewards Structure

Streamlined high-impact model per disease community:

3 Year 1 Annual rewards: one annual award for Alzheimer's, one for Cancer, and one for Long COVID
4 Quarterly Creative rewards: cross-condition Child, Teen, Young Adult, and Adult categories
Commemorative NFTs: All winners receive permanent blockchain recognition
Total launch plan: $8,750 in the moderate 2026 case across Alzheimer's, Cancer, and Long COVID, with full eight-community coverage completed by Q2 2027

Provider Recognition Pathway

Recognizing exceptional healthcare delivery and innovation across the care continuum remains part of the broader rewards architecture.

As enterprise-linked capacity expands beyond the initial Alzheimer's, Cancer, and Long COVID rollout, provider recognition can honor physicians, healthcare systems, aged care centers, pharmaceutical companies, AI healthcare providers, and other entities making measurable impact through innovative care delivery, patient support programs, product and service sponsorships, or breakthrough research.

Physicians: Specialists demonstrating exceptional patient care and compassion
Healthcare Systems: Hospitals or clinics implementing breakthrough care models
Aged Care Centers: Facilities providing dignity-focused chronic disease management
Pharmaceutical Companies: Organizations advancing research or accessibility
AI Healthcare Providers: Technology companies delivering diagnostic or care-coordination innovation
Other Healthcare Entities: Labs, imaging centers, home health agencies, and support organizations

Rollout Timing

The rewards page now uses one canonical rollout schedule only. The quarter-by-quarter expansion timing is defined once in Token Allocation so the dates stay consistent.

Program Architecture stays focused on what the model contains, while Token Allocation covers when each community enters. The high-level outcome is simple: 2026 establishes the initial expansion waves and full eight-community coverage is completed by Q2 2027.

Technology and Support

Blockchain Stories

Video creation preserves testimonials permanently, creating a global inspiration library accessible to anyone, anywhere, forever.

Recipient Support Services

Wallet Setup Assistance: One-on-one guidance for non-crypto users
Liquidation Guides: Step-by-step conversion to USDC or USD
Tax Reporting Help: Documentation and guidance for compliance
24/7 Support: Dedicated help for recipients

Award Values

Award Type	ICO Value	Token Amount
Community Engagement	$100	~11,400 PULSE tokens
Monthly Recognition	$1,000	~114,000 PULSE tokens
Annual Recognition	$5,000	~571,000 PULSE tokens

Values scale with token appreciation as the platform grows.

Mental Health Benefits

Receiving recognition through an award is not just ceremonial. For patients, caregivers, survivors, and providers, formal acknowledgment can interrupt the emotional invisibility that so often builds around chronic illness and long-term care. It tells people that their effort, fear, resilience, and contribution have been seen by others and are worthy of public respect.

That matters because morale is not a soft extra in chronic disease. Higher morale can support hope, identity, confidence, and willingness to stay engaged with treatment, caregiving, advocacy, and community life. Recognition also creates a social signal: you are not carrying this alone, and your story has value beyond the hardest day you are living through.

Across cancer and palliative-care literature, stronger social support is consistently associated with better quality of life, resilience, and psychological well-being, while dignity-focused interventions have shown benefits for hope, meaning, and emotional outcomes in advanced illness. That is why rewards can function as more than prizes. At their best, they become structured moments of validation, morale repair, and community connection.

Key Benefits

Validation and Recognition: rewards formally acknowledge courage, labor, and resilience that often go unseen in day-to-day care journeys.
Morale Boost: Recognition can lift confidence, strengthen hope, and help people feel that their fight or service genuinely matters.
Reduced Isolation: Public acknowledgment connects recipients to a wider community that sees, respects, and remembers their contribution.
Sense of Purpose: rewards can help transform suffering and effort into meaning, identity, and legacy beyond the illness itself.
Inspiration to Others: Recognized stories give other families and patients evidence that courage, care, and survival deserve to be honored.

Selected Evidence Base

Social support and quality of life: Luszczynska et al. found that social support is meaningfully associated with quality-of-life indicators in lung cancer patients (Psychooncology, 2013; PMID: 23097417).

Resilience, hope, and support: Sihvola et al. reported that resilience in colorectal cancer patients is associated with social support, hope, and quality of life (Eur J Oncol Nurs, 2022; PMID: 34844135).

Dignity-focused interventions: Meta-analyses of dignity therapy in advanced cancer and palliative care report benefits for hope, psychological well-being, dignity, and quality of life (Li et al., Depress Anxiety, 2020; PMID: 31808977; Xiao et al., Psychooncology, 2019; PMID: 31243850; Zhang et al., Int J Nurs Stud, 2022; PMID: 35635908).

Societal Impact

This program creates value far exceeding direct financial rewards. By combining tangible token rewards with profound emotional and mental health benefits, the Award Program delivers extraordinary societal value over time.

Dual-Impact Design: Recipients receive tangible rewards that provide immediate liquidity for critical needs, while their blockchain-preserved stories create exponential emotional value by inspiring countless others facing similar battles.

2026 Launch Funding Sensitivity

The current enterprise page now models 2026 ARR at $10.8M in the conservative case, $15M in the moderate case, and $22.8M in the aggressive case. Holding the rewards program at the same launch intensity puts the year-one funding envelope at roughly $6.3K-$13.3K, with the current $8.75K initial proof-cohort budget still matching the moderate case.

Enterprise-Linked Planning Snapshot

2026 Launch Budget: $6.3K-$13.3K across conservative to aggressive enterprise scenarios
2026-2030 Direct rewards Capacity: $1.12M-$2.19M using the same 0.0583% launch-intensity ratio
Emotional and Mental Health Value: $2.6M+ as a conservative 10-year floor
Multi-Disease Expansion: Expands in four rollout waves, moving from the initial proof cohort to all 8 disease and condition communities by Q2 2027

Calculating Emotional Value in Dollar Terms

We use a health economics approach to quantify the monetary value of non-financial outcomes including mental health improvements, reduced isolation, and quality-of-life gains.

Per-Recipient Emotional Value: $5,000

1. Mental Health Treatment Costs Avoided: $2,000-$3,000

Recognition reduces depression and anxiety
Saves therapy sessions and medication needs
Improves treatment compliance and outcomes

2. Reduced Isolation Value: $1,000-$1,500

Connection to community
Improved quality of life
Reduced readmissions and better health outcomes

3. Family Impact: $1,500

Reduced caregiver burden
Lower family anxiety and stress
Reduced burnout

4. Community Inspiration: Exponential Growth

Each blockchain story can be viewed by 100 to 500 people per year
Each viewer gains measurable inspiration and hope value
Permanent preservation ensures lasting impact

Conservative Methodology

Our $5,000 per-recipient estimate is deliberately modest. Actual mental health treatment for chronic disease patients often costs substantially more. We use conservative figures to keep projections defensible while still showing the scale of impact.

Sources and Methodology Notes

Clinical evidence base: The morale, hope, social-support, and dignity claims on this page are grounded in the literature cited in Mental Health Benefits, including Luszczynska et al. (Psychooncology, 2013; PMID: 23097417), Sihvola et al. (Eur J Oncol Nurs, 2022; PMID: 34844135), and dignity-therapy meta-analyses (PMIDs: 31808977, 31243850, 35635908).

Economic framing: The $5,000 per-recipient emotional-value proxy is a conservative planning estimate, not a formal cost-effectiveness or QALY model. It is built from modest ranges for avoided mental-health support costs, reduced isolation burden, caregiver spillover benefits, and downstream inspiration value from permanently accessible stories.

Forecast basis: The launch-budget, 2026-2030 capacity, and scaling examples below are derived from the current enterprise scenario framework: 2026 ARR of $10.8M, $15M, and $22.8M; 2027 moderate ARR of $130M; 2028 moderate ARR of $400M with an illustrative $4.0B valuation; and 2030 scenarios of $830M+, $1.3B, and $1.67B ARR.

Application rule: rewards budgets are calculated by applying the current moderate launch ratio of 0.0583% of ARR, based on the present $8.75K plan on $15M ARR, across the relevant enterprise milestones.

Enterprise-Linked rewards Capacity

The table below replaces the old placeholder market-cap scenarios with values tied directly to the enterprise forecast. It keeps the same launch intensity as the current $8.75K moderate 2026 plan, which allocates 0.0583% of ARR to the rewards program.

Scenario	2026 ARR	2028 IPO Valuation	2026-2030 Direct rewards Capacity	Planning Read
Conservative	$10.8M	$2.9B	$1.12M	Supports a disciplined initial proof cohort with measured expansion through the Q2 2027 completion timeline.
Moderate	$15M	$4.0B	$1.53M	Matches the current $8.75K initial proof-cohort budget and gives room for multi-disease expansion.
Aggressive	$22.8M	$5.6B	$2.19M	Creates headroom for faster expansion and materially larger annual award pools.

Method: 2026-2030 direct rewards capacity applies the current launch intensity of 0.0583% of ARR to each enterprise scenario from 2026 through 2030, then sums those annual budgets.

Source basis: enterprise scenario milestones are taken from the current Enterprise and Value Proposition planning pages, including the 2028 illustrative 10x ARR valuation framework.

Clinical Literature Reference Links

Luszczynska et al., 2013: Social support and quality of life in lung cancer patients. PubMed PMID 23097417
Sihvola et al., 2022: Resilience, hope, and social support in colorectal cancer patients. PubMed PMID 34844135
Li et al., 2020: Meta-analysis of dignity therapy in advanced cancer and palliative settings. PubMed PMID 31808977
Xiao et al., 2019: Dignity therapy evidence synthesis for psychological and quality-of-life outcomes. PubMed PMID 31243850
Zhang et al., 2022: Meta-analysis of dignity-focused interventions in palliative and cancer care. PubMed PMID 35635908

Planning and Forecast Sources

Enterprise Forecast: Source for 2026, 2027, 2028, and 2030 ARR scenario anchors, plus the illustrative 10x ARR valuation framework. Open Enterprise Page
Value Proposition: Source for synced year-one award structure and investor-facing framing of the rewards program. Open Value Proposition Page
rewards Methodology Notes: See the source and methodology notes above for the conservative emotional-value proxy and award-intensity ratio logic.
Mental Health Benefits Evidence Box: See the Mental Health Benefits section on this page for the inline morale, resilience, dignity, and social-support literature summary.

Token Allocation

This initiative celebrating warriors and caregivers serves as a key driver for PULSE token. By creating blockchain-preserved video testimonials, each recognition award generates authentic content that increases token utility and ecosystem value.

Economic Model Benefits

Rewards Warriors Directly: Recipients receive meaningful token allocations
Supports Community: The broader ecosystem benefits from increased engagement
Creates Value: Authentic stories drive platform growth and token utility
Network Expansion: Visibility attracts new participants and stakeholders
Virtuous Cycle: Recognition strengthens both individuals and the platform

A sustainable model that allows award recipients to liquidate at any time while maintaining token value requires careful token allocation structure. To keep this page readable, the schedule below is the single rollout timeline used across the rewards model.

Initial Assumptions

Year 1 proof cohort: 1 annual award each for Alzheimer's, Cancer, and Long COVID, plus 4 quarterly cross-condition creative rewards totaling $8,750 in the moderate 2026 case

Total Token Supply: 500 million tokens

Total Award Reserve: 4% of supply or 20 million tokens

Moderate 2026 Initial Allocation: Approximately 1 million tokens reserved for the Alzheimer's, Cancer, and Long COVID initial proof cohort, with later community expansion following the rollout schedule below

Canonical Rollout Timeline

Single Rollout Schedule

This is the only quarter-by-quarter rollout schedule used on this page.

Q3 2026: Cancer and Alzheimer's

Q4 2026: Long Covid and Parkinson's

Q1 2027: Obesity and Type II Diabetes

Q2 2027: Autism and Addiction

Completion point: All eight disease and condition communities are live by Q2 2027.

Token Reserve Allocation

Component	Allocation	Details
Total Award Reserve	4% (20M tokens)	Award pool with inflation protection built in
Moderate 2026 Initial Allocation	~0.2% (1M tokens)	Funds the Alzheimer's, Cancer, and Long COVID initial proof cohort at the current moderate 2026 budget.
Future Expansion Reserve	~3.8% (19M tokens)	Reserved for additional disease communities, larger future annual pools, and inflation protection.
Per Award Value	114K to 571K tokens	$1,000 to $5,000 at ICO price
Sustainability	Indefinite	Buyback mechanism plus enterprise revenue

Long-Term Sustainability Features

Inflation Protection Built In: Treasury structure maintains purchasing power over time
Buyback Program: Enterprise revenues continuously replenish the award pool
Token Appreciation: Fewer tokens are needed as platform value grows
No Additional Dilution: rewards are funded from operating cash flow

Implementation Structure

Time-Locked Treasury

Dedicated Multi-Sig Wallet

Create a secure multi-signature wallet holding the 4% warrior allocation, ensuring no single person can unilaterally access funds.

Quarterly Release Schedule

Q1: 1 quarterly creative award distributed
Q2: 1 quarterly creative award distributed
Q3: 1 quarterly creative award distributed
Q4: 1 quarterly creative award plus 3 annual rewards

Liquidation Mechanics

Recipient Support System

Private Wallet Setup Assistance: One-on-one guidance for wallet creation and security
Major rewards: 50% immediate, 50% vested over 3 months
Smaller rewards: 100% immediate release
Liquidation Guides: Exchange, tax, and support documentation

Governance Oversight

Community-Driven Decisions: Token holders can vote on award amounts, new categories, and geographic expansion through governance proposals.

rewards Budget Scaling Examples

Milestone	Forecast Input	Implied Annual rewards Budget	What It Supports
2026 Conservative Launch	$10.8M ARR	$6.3K	Supports the same 3 annual rewards plus 4 quarterly cross-condition creative rewards, with tighter launch-year sizing.
2026 Moderate Launch	$15M ARR	$8.75K	Current planning baseline for the Alzheimer's, Cancer, and Long COVID initial proof cohort.
2026 Aggressive Launch	$22.8M ARR	$13.3K	Preserves the launch structure while creating room for higher award values and stronger recipient support.
2027 Full-Platform Moderate	$130M ARR	$75.8K	Once all 8 disease and condition communities are live, the annual pool can broaden meaningfully across patients, caregivers, survivors, and future provider pathways.
2028 Moderate IPO Window	$400M ARR / $4.0B valuation	$233K	Supports a robust cross-condition rewards calendar with materially larger annual recognition pools.
2030 Conservative Scale	$830M+ ARR	$484K+	Funds a durable multi-community program while keeping treasury assumptions conservative.
2030 Moderate Scale	$1.3B ARR	$758K	Creates room for flagship rewards, caregiver relief grants, and deeper storytelling preservation.
2030 Aggressive Scale	$1.67B ARR	$974K	Provides major headroom for larger annual pools without changing the baseline allocation ratio.

Method: Each example keeps the same award-intensity ratio as the current moderate 2026 plan: $8.75K on $15M ARR, or 0.0583%, applied to the live enterprise forecast milestones.

Source basis: 2027, 2028, and 2030 forecast anchors follow the current scenario tables on the Enterprise page and the synced assumptions on Value Proposition.